Form 4 for IBRX ImmunityBio, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-31 · accession 0001326110-24-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-03 | 2023-12-31 | IBRX | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +34.5K | 220.1K | +19% | $0 |
| D | 2024-01-03 | 2023-12-31 | IBRX | Adcock Richard | CEO, Pres, Dir | F - Tax | $5.02 | -17.1K | 203.0K | -8% | -$85.8K |
| D | 2024-01-03 | 2023-12-31 | IBRX | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | -34.5K | 120.7K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-31 | M | A | 34,483 | $0.00 | 220,065 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-31 | F | D | 17,096 | $5.02 | 202,969 | D | — | — | (F1) On December 31, 2023, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on December 29, 2023 was the settlement price used to calculate the shares withheld. |
| 3 | Derivative | Restricted Stock Units | 2023-12-31 | M | D | 34,483 | $0.00 | 120,697 | D | — · — to — | 34,483 Common Stock | (F2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. (F3) Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026. |